AbbVie to present HCV data in November


AbbVie (ABBV +1.9%) will present new HCV data at AASLD in November.

Investors will get a look at SVR12 data from PEARL-1 and additional analyses from AVIATOR. (PR)

Worth remembering: ABT-450 was discovered in collaboration with Enanta (ENTA -0.1%).

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs